基于MRI的影像组学模型预测保乳手术切缘状态并推断乳腺癌肿瘤免疫微环境:一项多中心验证研究
该多中心验证研究回顾性收集三家医院接受保乳手术患者的术前乳腺MRI(SYMH n=296、SYSUCC n=131、TSPH n=143),在SYMH训练并外部验证影像组学模型预测切缘阳性风险。模型在测试队列和两个外部验证队列的AUC分别为0.78(0.66-0.90)、0.88(0.79-0.96)、0.76(0.68-0.84),低危与高危亚组实际切缘阳性率分别为0-10%与27.3-87.2%。切缘阳性与肿瘤区EMT及B细胞浸润升高、瘤周B细胞、未成熟树突状细胞和中性粒细胞浸润富集相关。
要点
- MRI影像组学模型(CSS模型)可术前评估保乳手术切缘阳性风险,测试队列AUC 0.78(0.66-0.90)。
- 模型可对患者进行风险分层:低危亚组切缘阳性率0-10%,高危亚组27.3-87.2%。
- 切缘阳性与肿瘤区EMT升高、B细胞浸润升高及瘤周免疫细胞浸润富集相关。
核心结论
- 基于MRI的影像组学预测模型可作为预测保乳手术切缘阳性风险的可靠工具,肿瘤免疫微环境改变与手术切缘状态相关。
研究设计与样本
- 多中心回顾性验证研究,收集三家医院接受保乳手术患者的术前乳腺MRI(SYMH n=296、SYSUCC n=131、TSPH n=143),在SYMH按7:3比例分为训练与测试队列训练影像组学模型,并在SYSUCC和TSPH队列进行外部验证。
关键影像表现/征象
- 模型整合多序列和多分割区域提取的特征构建影像组学评分(CSS模型)。
- 影像组学评分可将保乳手术患者分为切缘阳性风险不同的亚组。
- 切缘阳性者肿瘤区EMT水平及B细胞浸润较高。
- 切缘阳性者瘤周区B细胞、未成熟树突状细胞和中性粒细胞浸润富集。
诊断标准与关键数值
- 低危亚组实际切缘阳性率为0-10%,高危亚组为27.3-87.2%。
临床应用与阅片要点
- 该模型可用于保乳手术的术前规划,辅助评估切缘阳性风险。
- 作者指出需进一步研究不同切缘状态的肿瘤免疫微环境,以开发新的切缘评估指标并阐明其内在机制。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Accurate preoperative estimation of the risk of breast-conserving surgery (BCS) resection margin positivity would be beneficial to surgical planning. In this multicenter validation study, we developed an MRI-based radiomic model to predict the surgical margin status.
METHODS: We retrospectively collected preoperative breast MRI of patients undergoing BCS from three hospitals (SYMH, n = 296; SYSUCC, n = 131; TSPH, n = 143). Radiomic-based model for risk prediction of the margin positivity was trained on the SYMH patients (7:3 ratio split for the training and testing cohorts), and externally validated in the SYSUCC and TSPH cohorts. The model was able to stratify patients into different subgroups with varied risk of margin positivity. Moreover, we used the immune-radiomic models and epithelial-mesenchymal transition (EMT) signature to infer the distribution patterns of immune cells and tumor cell EMT status under different marginal status.
RESULTS: The AUCs of the radiomic-based model were 0.78 (0.66-0.90), 0.88 (0.79-0.96), and 0.76 (0.68-0.84) in the testing cohort and two external validation cohorts, respectively. The actual margin positivity rates ranged between 0-10% and 27.3-87.2% in low-risk and high-risk subgroups, respectively. Positive surgical margin was associated with higher levels of EMT and B cell infiltration in the tumor area, as well as the enrichment of B cells, immature dendritic cells, and neutrophil infiltration in the peritumoral area.
CONCLUSIONS: This MRI-based predictive model can be used as a reliable tool to predict the risk of margin positivity of BCS. Tumor immune-microenvironment alteration was associated with surgical margin status.
CLINICAL RELEVANCE STATEMENT: This study can assist the pre-operative planning of BCS. Further research on the tumor immune microenvironment of different resection margin states is expected to develop new margin evaluation indicators and decipher the internal mechanism.
KEY POINTS: • The MRI-based radiomic prediction model (CSS model) incorporating features extracted from multiple sequences and segments could estimate the margin positivity risk of breast-conserving surgery. • The radiomic score of the CSS model allows risk stratification of patients undergoing breast-conserving surgery, which could assist in surgical planning. • With the help of MRI-based radiomics to estimate the components of the immune microenvironment, for the first time, it is found that the margin status of breast-conserving surgery is associated with the infiltration of immune cells in the microenvironment and the EMT status of breast tumor cells.
引用
- Ma J, Chen K, Li S, et al. MRI-based radiomic models to predict surgical margin status and infer tumor immune microenvironment in breast cancer patients with breast-conserving surgery: a multicenter validation study. Eur Radiol. 2023. PMID: 37658888. doi:10.1007/s00330-023-10144-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。